Global Access to Lifesaving Therapies
Facilitating patient reach to FDA and EMA approved medicines regulated under legal frameworks
- Access to Global Medicines
- Regulatory-Compliant Imports
- Fast, Reliable Delivery
- Trusted by Leading Doctors
- No Hidden Charges
- Experts in Rare & Orphan Drugs
- Secure Cold-Chain Delivery
- Patient-Centric & Ethical
Our Services
Named Patient Program (NPP)
MitoGENE’s Named Patient Program offers patients legal access to life-saving international medications not yet available in their Country. By supporting patients and doctors with the necessary documentation, sourcing, and logistics, MitoGENE enables access to FDA/EMA-approved treatments through compassionate use regulations. The company ensures genuine products, faster delivery, and end-to-end compliance—making advanced global therapies accessible, affordable, and safe for those in urgent need.
Finished Formulations
MitoGENE partners with hospitals, specialty distributors, and clinics to supply authentic, high-quality pharmaceutical formulations —focused on oncology, rare diseases, and complex therapies. Sourced only from WHO-GMP certified manufacturers, MitoGENE ensures global delivery with cold-chain logistics, full documentation support, and fair pricing. MitoGENE simplifies the import process with fast turnaround and regulatory compliance, helping healthcare providers access essential treatments efficiently and cost-effectively
API Supply
MitoGENE offers high-purity Active Pharmaceutical Ingredients (APIs) sourced from certified Indian manufacturers, supporting pharmaceutical companies and research institutions globally. With a focus on oncology, cardiovascular, antiviral, and CNS therapies, MitoGENE ensures GMP-compliant sourcing, full technical documentation, and competitive pricing. While import licensing is client-handled, MitoGENE facilitates timely delivery through reliable logistics partners—positioning itself as a trusted access partner, not just a supplier.
Who We Serve

Patients & Physicians
Through Named Patient Program (NPP) we help patients legally access medicines unavailable in India through the Named Patient Import framework.
Patients: We guide individuals and families in accessing unapproved medicines for serious or rare conditions.
Physicians: We support doctors with required documentation and regulatory clarity for prescribing NPP medicines.

Hospitals, Clinics & Distributors
We supply WHO-GMP & GDP complaint Finished Formulations to healthcare institutions and licensed distributors globally.
Distributors: We work with licensed partners to deliver specialty medicines to markets with limited access.
Hospitals & Clinics: We provide quality formulations for critical care across key therapeutic areas.

Manufacturers, CMOs & R&D
We source high-purity APIs from certified Indian producers to support manufacturing and research.
R&D Institutions: Specialty and rare APIs available in flexible quantities for research needs
Manufacturers: Access compliant APIs for scalable, cost-effective production.
CMOs: Reliable sourcing with documentation for smooth regulatory compliance.
“We’re driven by purpose – to empower healthcare and research ecosystems with ethical, effective solutions”
Featured Products

Retsevmo

Daurismo

Pemazyre

ORSERDU

COLUMVI

Talvey

LUMYKRAS

Ninlaro

Lytgobi




